Results 11 to 20 of about 2,044 (190)

SGLT2 inhibitors for the prevention and treatment of heart failure: A scientific statement of the HFA and the HFAI [PDF]

ESC Heart Failure
In the 2021 European Society of Cardiology (ESC) heart failure (HF) guidelines, sodium–glucose cotransporter 2 (SGLT2) inhibitors were recommended for the prevention of HF in patients with type 2 diabetes mellitus (T2DM) and for the treatment of HF with ...
Marco Metra, Daniela Tomasoni, Marianna Adamo, Offer Amir, Stefan D. Anker, Antoni Bayes‐Genis, Michael Boehm, Javed Butler, Ovidiu Chioncel, Gerasimos Filippatos, Finn Gustafsson, Ewa A. Jankowska, Juan Carlos Kaski, Brenda Moura, Mark C. Petrie, Piotr Ponikowski, Amina Rakisheva, Arsen Ristic, Francois Roubille, Gianluigi Savarese, Petar Seferovic, Peter van derMeer, Maurizio Volterrani, Andrew J. Coats, Vijay K. Chopra, Giuseppe Rosano   +25 more
doaj   +3 more sources

Empagliflozin in acute myocardial infarction in patients with and without type 2 diabetes: A pre-specified analysis of the EMPACT-MI trial. [PDF]

Eur J Heart Fail
Glycaemic status and diabetes in EMPACT‐MI. HF, heart failure; LVEF, left ventricular ejection fraction; MI, myocardial infarction. Abstract Aims In the EMPACT‐MI trial, empagliflozin reduced heart failure (HF) hospitalizations but not mortality in acute myocardial infarction (MI).
Petrie MC, Udell JA, Anker SD, Harrington J, Jones WS, Mattheus M, Gasior T, van der Meer P, Amir O, Bahit MC, Bauersachs J, Bayes-Genis A, Chopra VK, Januzzi JL, Lopes RD, Ponikowski P, Rossello X, Schou M, Zieroth S, Brueckmann M, Sumin M, Bhatt DL, Hernandez AF, Butler J.   +23 more
europepmc   +4 more sources

Assessment of the Empact of IGC‐AD1 on Hepatic Biomarkers in Alzheimer’s Disease: Insights from a Phase 1 Trial [PDF]

Alzheimers Dement
Abstract Background IGC‐AD1 comprises of Tetrahydrocannabinol (“THC”) and melatonin. The two active pharmaceuticals are known for their neuroprotective properties. In this analysis we studied multiple dosing of IGC‐AD1 in Alzheimer’s (“AD”) populations vulnerable to hepatic complications.
Rodriguez‐Soacha D, Cañon A, Sánchez L, Rao J, Delgado‐Murillo L, Venegas M, Tangarife M, Arbelaez M, Gutiérrez E, Shahnawaz S, Ghazaryan V, De Jesus W, Grimaldi C, Hong E, Mukunda R.   +14 more
europepmc   +4 more sources

An overview of EMPaCT and fundamental issues affecting minority participation in cancer clinical trials: Enhancing minority participation in clinical trials (EMPaCT): Laying the groundwork for improving minority clinical trial accrual [PDF]

Cancer, 2014
This supplement provides an overview of the interventional efforts as well as scientific data regarding the undertaking by the EMPaCT consortium to document the scope of the problem and the results from multiple methods of interventions for increasing minority accrual in clinical trials.
Selwyn M, Vickers, Mona N, Fouad
openaire   +4 more sources

Baseline characteristics of patients enrolled in the EMPACT-MI trial [PDF]

European Heart Journal, 2023
Abstract Background Empagliflozin has been shown to reduce the risk of adverse cardiovascular (CV) outcomes in patients with type 2 diabetes (T2DM) and in those with heart failure (HF). The impact of empagliflozin in post-acute myocardial infarction (AMI) patients is unknown.
Javed Butler
openaire   +2 more sources

EMPaCT: Co-building partnerships with diverse patients to promote health equity

International Journal of Integrated Care, 2022
Workshop – BackgroundAn important challenge of patient engagement is including people from diverse communities whose voices are seldom-heard. Exclusionary institutional practices and tokenistic methods inhibit meaningful relationships with the necessary variety of people needed to move towards an equitable healthcare system.
Sayani, Ambreen, Maybee, Alies
openaire   +4 more sources

Empact of obesity on clinical and laboratory parameters of patients with chronic pancreatitis

Herald of Pancreatic Club
Introduction. Among digestive diseases, chronic pancreatitis (HP) is noted in 5–9% of cases. In Ukraine, over the past 10 years, the prevalence of this disease has increased threefold, among adolescents — 4 times. After the diagnosis of HP and even treatment, in the next 10 years, 25% of patients become disabled with irreversible morphological changes ...
N. V. Bieliaieva, L. S. Kiro, M. Y. Zak
openaire   +3 more sources

The empact CVT : dynamics and control of an electromechanically actuated CVT

, 2007
The large ratio coverage of a CVT and the possibility to choose the engine speed in a wide range independently of the vehicle speed enables the ICE to operate at more fuel economic operating points, making the vehicle potentially more fuel efficient.
Twgl Tim Klaassen
openaire   +3 more sources

Environmental empact essessment procedure of the lake Vostok sampling as a tool of the Antarctic ecosistems protection

RUDN Journal of Law, 2012
The article analyzes the evolution of the environmental impact assessment (EIA) procedures in the Antarctic. The provisions of various international instruments governing this procedure are compared with other models of EIA, on the basis of experience of
S M Kopylov
doaj   +1 more source

Organizational Ethos: Empact on Work Performance of Employees

Cognition
The objective of this study is to explore how organizational ethos affects employees' work performance. This study is based on meta-analysis research design and the literature review. Organizational principles, practices, and distinctive features of culture all contribute to the dimension of corporate culture.
Narayan Prasad Adhikari, Jhupa Kumari Budhathoki   +1 more
openaire   +3 more sources